Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses

Area of Science:

• Immunology
• Neonatal Health
• Respiratory Medicine

Background:

• Infants born to mothers who smoke exhibit higher incidences of respiratory infections, asthma, and airway diseases.
• Maternal smoking during pregnancy is a significant public health concern with potential long-term consequences for infant health.

Purpose of the Study:

• To investigate the impact of maternal smoking during pregnancy on neonatal toll-like receptor (TLR)-mediated immune responses.
• To determine if altered neonatal immune responses contribute to the increased respiratory illness rates observed in infants of smokers.

Main Methods:

• A prospective birth cohort study comparing immune responses in neonates from smoking and non-smoking mothers.
• Measurement of maternal and cord serum cotinine levels to quantify cigarette smoke exposure.
• Assessment of neonatal cytokine responses to stimulation with TLR2, TLR3, TLR4, and TLR9 ligands.

Main Results:

• Cotinine levels confirmed higher cigarette smoke exposure in mothers and neonates from the smoking group.
• Infants of smoking mothers demonstrated significantly attenuated innate immune responses mediated by toll-like receptors (TLRs) compared to infants of non-smoking mothers.
• These suppressed TLR-mediated responses may also affect regulatory pathways involved in allergic immune responses.

Conclusions:

• Maternal smoking during pregnancy has detrimental immunological effects on neonates, impacting TLR-mediated innate immunity.
• These immunological alterations, alongside effects on airway development, likely contribute to the increased risk of respiratory infections and asthma in infants of smokers.
• The findings suggest that maternal smoking-induced immune modulation is a key factor in the elevated respiratory morbidity observed in these infants.